Provention Bio logo
Provention Bio PRVB

Annual report 2022
added 03-29-2023

report update icon

Provention Bio Long Term Debt Current 2011-2026 | PRVB

Annual Long Term Debt Current Provention Bio

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
151 K 125 K - - - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
151 K 125 K 138 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
103 K - 5743.5 % $ 69.7 M canadaCanada
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
MannKind Corporation MannKind Corporation
MNKD
2.11 M $ 3.56 24.48 % $ 1.09 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Bio-Techne Corporation Bio-Techne Corporation
TECH
14.1 M $ 47.41 -16.36 % $ 7.47 B usaUSA
Athira Pharma Athira Pharma
ATHA
465 K - - $ 269 M usaUSA
BioNTech SE BioNTech SE
BNTX
45 M - - $ 27.2 B germanyGermany
INmune Bio INmune Bio
INMB
623 K $ 1.52 -1.3 % $ 37.6 M usaUSA
Exelixis Exelixis
EXEL
27.9 M $ 48.7 9.64 % $ 13.2 B usaUSA
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
9.96 M $ 21.48 -3.89 % $ 3.56 B usaUSA
Fortress Biotech Fortress Biotech
FBIO
2.13 M - - $ 71.1 M usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
2.1 M $ 3.15 1.19 % $ 655 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K - - $ 5.51 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
215 K - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Allakos Allakos
ALLK
3.25 M - - $ 28.6 M usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 24.17 3.2 % $ 3.08 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
274 K - -11.43 % $ 502 K usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
756 K - - $ 2.17 B usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
Aravive Aravive
ARAV
2.2 M - -13.39 % $ 1.45 M usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
538 K - 17.91 % $ 11.1 M usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
18.6 M $ 55.08 5.15 % $ 4.95 B schweizSchweiz
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.7 3.66 % $ 452 M britainBritain
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael